Research Article
BibTex RIS Cite

Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up

Year 2021, Volume: 4 Issue: 3, 81 - 86, 25.12.2021

Abstract

Objective: To determine the risk factors for recurrence in endoscopically treated frontoethmoid mucoceles.

Methods: A retrospective study was designed. The patients with frontoethmoidal mucoceles who underwent endonasal surgical approach and followed up for a minimum of 4 years were included. The demographic data of patients, symptoms, etiological and prognostic features, location, and classification of the mucocele were recorded.

Results: Sixty-four patients were included in the study. The mean age of patients was 45.2 [range: 10-83, standard deviation (SD):618.2], and the male: female ratio was 0.72. The mean follow-up duration was 75 months (min. 52, max. 168 months, SD: 42.1). Bone erosion at lamina papyracea was detected in 30 patients (46.9%), orbital roof (n¼ 20, 31.3%), and ethmoid roof (n¼ 15, 23.4%). Major complications were encountered in two patients (% 8). During follow-up (mean: 75 months min. 52, max. 168, SD: 42.1), recurrence was found in eight cases (12.5%). Comparison of risk factors regarding recurrence of mucocele after surgery showed statistical significance for posterior frontal wall dehiscence (P¼ .014) and revision endoscopic surgery (P¼ .005). However, further analysis with binary logistic regression, revision nasal endoscopic sinus surgery was the only significant risk factor for mucocele recurrence (P¼ .047, odds ratio: 6.43).

Conclusion: Endoscopic endonasal marsupialization of frontoethmoid mucoceles is a safe and efficient for management. A long-term follow-up is important for the accurate assessment of recurrence. The presence of revision nasal surgery was a significant risk factor for recurrence, so, more extensive surgeries can be considered to minimize the risk.

References

  • Stiernberg CM, Bailey BJ, Calhoun KH, Quinn FB. Management of invasive frontoethmoidal sinus mucoceles. Arch Otolaryngol Head Neck Surg. 1986;112(10):1060-1063.
  • Herndon M, McMains KC, Kountakis SE. Presentation and management of extensive fronto-orbital-ethmoid mucoceles. Am J Otolaryngol. 2007;28(3):145-147.
  • Nazar R, Naser A, Pardo J, Fulla J, Rodrı´guez-Jorge J, Delano PH. Manejo endoscópico de mucoceles de senos paranasales: Experiencia en 46 pacientes [Endoscopic management of paranasal sinus mucoceles: Experience with 46 patients]. Acta Otorrinolaringol Esp. 2011;62(5):363-366.
  • Sautter NB, Citardi MJ, Perry J, Batra PS. Paranasal sinus mucoceles with skullbase and/or orbital erosion: Is the endoscopic approach sufficient? Otolaryngol Head Neck Surg. 2008;139(4):570-574.
  • Conboy PJ, Jones NS. The place of endoscopic sinus surgery in the treatment of paranasal sinus mucocoeles. Clin Otolaryngol. 2003;28(3):207-210.
  • Scangas GA, Gudis DA, Kennedy DW. The natural history and clinical characteristics of paranasal sinus mucoceles: A clinical review. Int Forum Allergy Rhinol. 2013;3(9):712-717.
  • Obeso S, Llorente JL, Pablo Rodrigo J, Sa´nchez R, Mancebo G, Sua´rez C. Mucoceles de senos paranasales. Nuestra experiencia en 72 pacientes [Paranasal sinuses mucoceles. Our experience in 72 patients]. Acta Otorrinolaringol Esp. 2009;60(5):332-339.
  • Khong JJ, Malhotra R, Selva D, Wormald PJ. Efficacy of endoscopic sinus surgery for paranasal sinus mucocele including modified endoscopic Lothrop procedure for frontal sinus mucocele. J Laryngol Otol. 2004;118(5):352-356.
  • Har-El G. Endoscopic management of 108 sinus mucoceles. Laryngoscope. 2001;111(12):2131-2134.
  • Courson AM, Stankiewicz JA, Lal D. Contemporary management of frontal sinus mucoceles: A meta-analysis. Laryngoscope. 2014;124(2):378-386.
  • Benkhatar H, Khettab I, Sultanik P, Laccourreye O, Bonfils P. Mucocele development after endoscopic sinus surgery for nasal polyposis: A long-term analysis. Ear Nose Throat J. 2018;97(9):284-294.
  • Har-El G. Transnasal endoscopic management of frontal mucoceles. Otolaryngol Clin N Am. 2001;34(1):243-251.
  • Serrano E, Klossek JM, Percodani J, Yardeni E, Dufour X. Surgical management of paranasal sinus mucoceles: A long-term study of 60 cases. Otolaryngol Head Neck Surg. 2004;131(1):133-140.
  • Kennedy DW, Josephson JS, Zinreich SJ, Mattox DE, Goldsmith MM. Endoscopic sinus surgery for mucoceles: A viable alternative. Laryngoscope. 1989;99(9):885-895.
  • Bockmühl U, Kratzsch B, Benda K, Draf W. Surgery for paranasal sinus mucocoeles: Efficacy of endonasal micro-endoscopic management and long-term results of 185 patients. Rhinology. 2006;44(1):62-67.
  • du Mayne MD, Moya-Plana A, Malinvaud D, Laccourreye O, Bonfils P. Sinus mucocele: Natural history and long-term recurrence rate. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129(3):125-130.
There are 16 citations in total.

Details

Primary Language English
Subjects Otorhinolaryngology
Journal Section Research Article
Authors

Erdem Eren 0000-0003-4475-3250

Akif İşlek 0000-0001-7058-3457

Uygar Levent Demir This is me 0000-0002-9590-1420

Sercan Göde 0000-0002-2148-0723

Halil Karcı 0000-0002-1079-4428

Publication Date December 25, 2021
Published in Issue Year 2021 Volume: 4 Issue: 3

Cite

APA Eren, E., İşlek, A., Demir, U. L., … Göde, S. (2021). Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. European Journal of Rhinology and Allergy, 4(3), 81-86. https://doi.org/10.5152/ejra.2021.21046
AMA Eren E, İşlek A, Demir UL, Göde S, Karcı H. Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. Eur J Rhinol Allergy. December 2021;4(3):81-86. doi:10.5152/ejra.2021.21046
Chicago Eren, Erdem, Akif İşlek, Uygar Levent Demir, Sercan Göde, and Halil Karcı. “Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study With Long-Term Follow-up”. European Journal of Rhinology and Allergy 4, no. 3 (December 2021): 81-86. https://doi.org/10.5152/ejra.2021.21046.
EndNote Eren E, İşlek A, Demir UL, Göde S, Karcı H (December 1, 2021) Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. European Journal of Rhinology and Allergy 4 3 81–86.
IEEE E. Eren, A. İşlek, U. L. Demir, S. Göde, and H. Karcı, “Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up”, Eur J Rhinol Allergy, vol. 4, no. 3, pp. 81–86, 2021, doi: 10.5152/ejra.2021.21046.
ISNAD Eren, Erdem et al. “Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study With Long-Term Follow-up”. European Journal of Rhinology and Allergy 4/3 (December2021), 81-86. https://doi.org/10.5152/ejra.2021.21046.
JAMA Eren E, İşlek A, Demir UL, Göde S, Karcı H. Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. Eur J Rhinol Allergy. 2021;4:81–86.
MLA Eren, Erdem et al. “Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study With Long-Term Follow-up”. European Journal of Rhinology and Allergy, vol. 4, no. 3, 2021, pp. 81-86, doi:10.5152/ejra.2021.21046.
Vancouver Eren E, İşlek A, Demir UL, Göde S, Karcı H. Risk Factors for Recurrence in Endoscopically Treated Fronto-Ethmoid Mucoceles: A Multi-Institutional Retrospective Study with Long-term Follow-up. Eur J Rhinol Allergy. 2021;4(3):81-6.

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.